Actinomycin D treatment and RNA stability analysis

CO Cristina Oliveira-Mateos
AS Anaís Sánchez-Castillo
MS Marta Soler
AO Aida Obiols-Guardia
DP David Piñeyro
RB Raquel Boque-Sastre
MC Maria E. Calleja-Cervantes
MM Manuel Castro de Moura
AM Anna Martínez-Cardús
TR Teresa Rubio
JP Joffrey Pelletier
MM Maria Martínez-Iniesta
DH David Herrero-Martín
OT Oscar M. Tirado
AG Antonio Gentilella
AV Alberto Villanueva
ME Manel Esteller
LF Lourdes Farré
SG Sonia Guil
request Request a Protocol
ask Ask a question
Favorite

Control or RPSAP52-depleted A673 clones were treated with either 0.5% DMSO or 5 µg ml−1 Actinomycin D (Sigma) for 9 h. Pellets of each condition and treatment were harvested at different times and RNA was extracted for the RT-qPCR experiments. All data were normalized with respect to GUSB as endogenous control and gene expression fold-changes induced by Actinomycin D were calculated relative to the control (DMSO) cells of each condition and time point. c-FOS and GAPDH were used as controls of the experiment due to their short and long half-life, respectively.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A